The Company's comprehensive portfolio of
adult-use brands and products will be sold online and at licensed
retailers across the province
LEAMINGTON, ON, July 12, 2018 /CNW/ - Aphria Inc.
("Aphria" or the "Company") (TSX: APH and
US OTC: APHQF) today announced that it has signed a
Memorandum of Understanding (the "MOU") with the British
Columbia Liquor Distribution Branch ("BCLDB") to provide a
portfolio of high-quality, branded cannabis and cannabis derivative
products for sale in BC's adult-use market.
Under the terms of the MOU, Aphria will supply more than 5,000
kg of high-quality cannabis in the first year of the agreement,
which will be made available for sale online and at licensed
retailers across the province. Adult-use consumers will be able to
choose from a wide-ranging selection of Ontario and BC dried flower, pre-rolls and
cannabis oils from the Company's portfolio of adult-use brands.
"We're incredibly proud that the BCLDB has selected our
fantastic range of products and brands to be sold at the province's
licensed retailers starting on October
17," said Jakob Ripshtein, Chief Commercial Officer at
Aphria. "Both long-time enthusiasts and newcomers to cannabis will
find that our adult-use brands and products, which include
locally-grown and celebrated BC-bud from Broken Coast Cannabis,
have been thoughtfully developed to meet distinct consumer needs
and interests. We are thrilled to provide adult-use consumers in
B.C. the opportunity to discover our brands, and to help ensure
that there is an adequate supply to meet the anticipated demand in
the province."
Aphria is continuing to demonstrate its readiness to provide
both adequate supply and a deep selection of high-quality products
across Canada starting in October.
With previously announced supply agreements in Quebec, Manitoba, Alberta and New
Brunswick and a cross-Canada partnership with Great North
Distributors, the Company is well-prepared to meet the anticipated
demand in the adult-use market. Aphria is also developing a range
of innovative cannabis products that are expected to be made
available in BC and elsewhere once authorized for sale under the
Cannabis Act.
"Aphria has the infrastructure, know-how and capacity to deliver
on our commitments to B.C. and across Canada once the opening bell rings," said
Vic Neufeld, Chief Executive Officer
at Aphria. "Not only are we well-prepared, but also we are
confident that our thoughtfully researched and developed portfolio
of adult-use brands will resonate with consumers. Our company-wide
focus on innovation, including our new Extraction Centre of
Excellence, will also ensure that Aphria remains on the leading
edge of tomorrow's cannabis products that will revolutionize the
way consumers integrate cannabis into their lives."
We Have a Good Thing Growing
About Aphria
Aphria is a leading global cannabis company driven by an
unrelenting commitment to our people, product quality and
innovation. Headquartered in Leamington,
Ontario – the greenhouse capital of Canada – Aphria has been setting the standard
for the low-cost production of safe, clean and pure
pharmaceutical-grade cannabis at scale, grown in the most natural
conditions possible. Focusing on untapped opportunities and backed
by the latest technologies, Aphria is committed to bringing
breakthrough innovation to the global cannabis market. The
Company's portfolio of brands is grounded in expertly-researched
consumer insights designed to meet the needs of every consumer
segment. Rooted in our founders' multi-generational expertise in
commercial agriculture, Aphria drives sustainable long-term
shareholder value through a diversified approach to innovation,
strategic partnerships and global expansion, with a presence in
more than 10 countries across 5 continents.
For more information, visit: aphria.ca
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend" or the negative of these terms and similar expressions.
Forward-looking statements in this news release include, but are
not limited to, statements with respect to internal expectations,
estimated margins, expectations with respect to actual production
volumes, expectations of shipments to Provincial Liquor Control
Boards expectations for future growing capacity and costs, the
completion of any capital project or expansions, and expectations
with respect to future production costs. Forward-looking statements
necessarily involve known and unknown risks, including, without
limitation, risks associated with general economic conditions;
adverse industry events; marketing costs; loss of markets; future
legislative and regulatory developments involving medical
marijuana; inability to access sufficient capital from internal and
external sources, and/or inability to access sufficient capital on
favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory
matters; the ability of Aphria to implement its business
strategies; competition; crop failure; currency and interest rate
fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those
anticipated.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
SOURCE Aphria Inc.